Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT03017794
Eligibility Criteria:
Inclusion Criteria:
* Clinically localized prostate carcinoma, T1-T4 N0M0, any Gleason Score, any prostate-specific antigen (PSA), or Biochemical relapse with clinically suspicious (based on MRI or clinical examination) or biopsy-proven local recurrence in the prostatic fossa after a radical prostatectomy
* ≥18 years old
* Histologic diagnosis of prostate adenocarcinoma
* Signed informed consent
Exclusion Criteria:
* Biochemical relapse alone without clinically suspicious (i.e. no suspicious lesion on MRI of the prostatic bed) or biopsy-proven local recurrence in the prostatic fossa
* Regional pelvic node metastasis (N1)
* Distant metastasis (M1)
* Concurrent or previous cytotoxic medications
* Medical or psychological conditions that in the opinion of the investigator would not allow follow-up
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT03017794
Study Brief:
Protocol Section:
NCT03017794